A Phase 2, Open-Label, Multi-Center Study of Venetoclax in Combination with Carfilzomib and Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma
Administered By
Awarded By
Contributors
- Gasparetto, Cristina Principal Investigator
Start/End
- May 22, 2018 - February 28, 2023